Menu Close

Johns Hopkins and Kaiser Permanente Collaboration Pilot Awards

The Johns Hopkins and Kaiser Permanente Research Collaboration Committee would like to announce the solicitation of applications for the 2023 Kaiser Permanente Mid-Atlantic States / Johns Hopkins Medicine (KPMAS/JHM) Research Collaboration Program.

The 2022 application period is closed.


The KPMAS/JHM Research Collaboration Program seeks to fund research projects that highlight the effective synergy of the KPMAS/JHM collaboration in tackling the complex and intriguing questions vexing both health systems. Research projects within this program should best represent initial research that leverages the unique capabilities of KP and JHM as learning health systems.

KPMAS/JHM Research Collaboration projects are generally pilot projects that may expand into more complex research inquiries and proposals in the future. Funded projects will be managed by two co-Principal Investigators (PIs); one from KP and one from JHM. If an investigator has an idea for a project but does not know a potential research collaborator/colleague from JHM, the leaders at MAPRI and JHM will endeavor to make introductions on their behalf.


The KPMAS/JHM Research Collaboration Program is for 12-month projects that are non-renewable. Funding is available for up to four projects with a total of $75,000/project. No indirect costs are allowed. Funding will not start any sooner than April 1, 2023, pending Institutional Review Board review and approval.


To view our webinar, which provided an overview of the program, application, and submission process, email the ICTR at or Karen Chesbrough (MAPRI) at

Please review the KP/JHM Research Collaboration Program Overview or visit the Kaiser Permanente Mid-Atlantic States/Johns Hopkins Medicine Research Collaboration Program – Mid-Atlantic Permanente Research Institute website for a full description of the program as well as funding priorities, program objectives, eligibility, and application.

Contact Karen Chesbrough (MAPRI) at or Carol Kobrin (JHM) at with questions.